SARS-CoV-2: Rapid Antigen Test - India CDSCO Medical Device Registration
SARS-CoV-2: Rapid Antigen Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000020_be3deebeaf3c3bbca746363ba68cc1a1_fa5e492113939d89d989f98328feb573. The license holder is Koshbio Private Limited, and it is classified as Device Class Class C. The approving authority is Sub Zonal Baddi.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
License Holder
Koshbio Private LimitedDevice Class
Approving Authority
Sub Zonal Baddi
Product Information
SARS-CoV-2: Rapid Antigen Test is a rapid immunoassay for the qualitative detection of antigen of corona virus (NA) in human nasopharyngeal swab specimen to an aid in the diagnosis of infection with corona virus (NA). For in-vitro diagnostic use only.
